These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21949843)

  • 21. Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells?
    Sestito C; Brevé JJP; van Eggermond MCJA; Killestein J; Teunissen CE; van Rossum J; Wilhelmus MMM; Drukarch B; van den Elsen PJ; van Dam AM
    J Neuroinflammation; 2017 Dec; 14(1):257. PubMed ID: 29268771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis.
    Chrobok NL; Bol JGJM; Jongenelen CA; Brevé JJP; El Alaoui S; Wilhelmus MMM; Drukarch B; van Dam AM
    PLoS One; 2018; 13(4):e0196433. PubMed ID: 29689097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid hormone modulates the extracellular matrix organization and expression in cerebellar astrocyte: effects on astrocyte adhesion.
    Trentin AG; De Aguiar CB; Garcez RC; Alvarez-Silva M
    Glia; 2003 Jun; 42(4):359-69. PubMed ID: 12730956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced osteoblast adhesion on transglutaminase 2-crosslinked fibronectin.
    Forsprecher J; Wang Z; Nelea V; Kaartinen MT
    Amino Acids; 2009 Apr; 36(4):747-53. PubMed ID: 18604470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses.
    Stephens P; Grenard P; Aeschlimann P; Langley M; Blain E; Errington R; Kipling D; Thomas D; Aeschlimann D
    J Cell Sci; 2004 Jul; 117(Pt 15):3389-403. PubMed ID: 15199098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin.
    Akimov SS; Krylov D; Fleischman LF; Belkin AM
    J Cell Biol; 2000 Feb; 148(4):825-38. PubMed ID: 10684262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transglutaminase type 2 in human abdominal aortic aneurysm is a potential factor in the stabilization of extracellular matrix.
    Shin S; Cho YP; Jun H; Park H; Hong HN; Kwon TW
    J Vasc Surg; 2013 May; 57(5):1362-70. PubMed ID: 23538006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway.
    Wang X; Yu Z; Zhou Q; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
    Oncotarget; 2016 Feb; 7(6):7066-79. PubMed ID: 26771235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced neural differentiation of neural stem cells by sustained release of Shh from TG2 gene-modified EMSC co-culture in vitro.
    Shi W; Bian L; Lv D; Bi S; Dai Y; Yang K; Lu H; Zhou H; Que Y; Wang D; Zhang Z; Lu N
    Amino Acids; 2021 Jan; 53(1):11-22. PubMed ID: 33245424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue transgluaminase 2 expression in meningiomas.
    Yuan L; Behdad A; Siegel M; Khosla C; Higashikubo R; Rich KM
    J Neurooncol; 2008 Nov; 90(2):125-32. PubMed ID: 18587533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.
    Colak G; Johnson GV
    Neurobiol Dis; 2012 Mar; 45(3):1042-50. PubMed ID: 22198379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracellular transglutaminase 2 has a role in cell adhesion, whereas intracellular transglutaminase 2 is involved in regulation of endothelial cell proliferation and apoptosis.
    Nadalutti C; Viiri KM; Kaukinen K; Mäki M; Lindfors K
    Cell Prolif; 2011 Feb; 44(1):49-58. PubMed ID: 21199009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
    van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
    Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular functions of tissue transglutaminase.
    Nurminskaya MV; Belkin AM
    Int Rev Cell Mol Biol; 2012; 294():1-97. PubMed ID: 22364871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification.
    Johnson KA; Terkeltaub RA
    J Biol Chem; 2005 Apr; 280(15):15004-12. PubMed ID: 15691824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GPR56 inhibits melanoma growth by internalizing and degrading its ligand TG2.
    Yang L; Friedland S; Corson N; Xu L
    Cancer Res; 2014 Feb; 74(4):1022-31. PubMed ID: 24356421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor-beta 2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes.
    Fuchshofer R; Birke M; Welge-Lussen U; Kook D; Lütjen-Drecoll E
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):568-78. PubMed ID: 15671284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury.
    Feola J; Barton A; Akbar A; Keillor J; Johnson GVW
    Brain Res; 2017 Aug; 1668():1-11. PubMed ID: 28522262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of tissue transglutaminase expression in malignant melanoma.
    Fok JY; Ekmekcioglu S; Mehta K
    Mol Cancer Ther; 2006 Jun; 5(6):1493-503. PubMed ID: 16818508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thy-1-mediated cell-cell contact induces astrocyte migration through the engagement of αVβ3 integrin and syndecan-4.
    Kong M; Muñoz N; Valdivia A; Alvarez A; Herrera-Molina R; Cárdenas A; Schneider P; Burridge K; Quest AF; Leyton L
    Biochim Biophys Acta; 2013 Jun; 1833(6):1409-20. PubMed ID: 23481656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.